熱門資訊> 正文
Aytu Bizerma宣布出售消费者健康业务
2024-08-06 20:54
- Aytu BioPharma (NASDAQ:AYTU) announced that following the wind down of operations, it has entered into a definitive agreement to divest its Consumer Health (a/k/a Innovus Pharmaceuticals) business to a private, e-commerce focused company.
- The divested business encompasses the established e-commerce platform, certain inventory and associated consumer brands, intellectual property, contracts and liabilities, and provides for Aytu to receive revenue-based royalty payments on future sales of former Consumer Health business products.
- Source: Press Release
More on Aytu BioScience
- Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript
- Aytu Biopharma announces paydown and refinancing of term loan
- Aytu BioPharma up 5% as quarterly results beat on both lines
- Seeking Alpha’s Quant Rating on Aytu BioScience
- Historical earnings data for Aytu BioScience
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
